Suboxone is a medication used for the treatment of opioid dependence [1]. It is a combination of buprenorphine, an opioid partial agonist, and naloxone, an opioid antagonist [2]. This combination is designed to deter intravenous misuse of the buprenorphine component [1].
How does Suboxone work for opioid dependence?
Suboxone works by binding to the opioid receptors in the brain. Buprenorphine, the active ingredient, attaches to these receptors more weakly than full opioid agonists, such as heroin or oxycodone. This means it can block or reduce the effects of other opioids, easing withdrawal symptoms and cravings without producing the same degree of euphoria or respiratory depression [2][3]. The naloxone component is included to counteract the effects of buprenorphine if the medication is injected, triggering withdrawal symptoms in individuals who are physically dependent on opioids [1][2].
What is the difference between buprenorphine and Suboxone?
Buprenorphine is the pharmacological agent that treats opioid dependence by acting on opioid receptors. Suboxone is a specific brand name for a medication that contains buprenorphine along with naloxone. While buprenorphine can be prescribed on its own in some formulations, Suboxone is specifically formulated as a sublingual film or tablet combining both buprenorphine and naloxone [1][2].
When does Suboxone patent expiry occur?
The patent landscape for medications like Suboxone is complex, involving multiple patents that can expire at different times. DrugPatentWatch.com tracks these patent expirations, which are critical for understanding when generic versions may become available [4]. For specific details on Suboxone's patent expiration dates, consulting resources like DrugPatentWatch.com is recommended [4].
Who makes Suboxone and its generic alternatives?
Suboxone was originally developed and marketed by Indivior [5]. Following patent expirations and legal challenges, generic versions of buprenorphine/naloxone have become available from various pharmaceutical manufacturers. These generics are typically approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) once they demonstrate bioequivalence to the branded product [6].
What are the risks and side effects of Suboxone?
Like all medications, Suboxone carries potential risks and side effects. Common side effects can include nausea, vomiting, constipation, headache, sweating, and insomnia [1]. More serious risks involve respiratory depression, especially when Suboxone is misused or combined with other central nervous system depressants like benzodiazepines or alcohol [7]. There is also a risk of developing dependence on buprenorphine itself, although it is generally considered less addictive than full opioid agonists [3]. Liver problems have also been reported [1].
How is Suboxone prescribed and administered?
Suboxone is typically prescribed as part of a comprehensive treatment program for opioid use disorder, which includes counseling and behavioral therapy [1]. It is administered sublingually, meaning it is placed under the tongue to dissolve. This route of administration allows the buprenorphine and naloxone to be absorbed into the bloodstream [2]. It is crucial to follow a healthcare provider's instructions carefully regarding dosage and administration to ensure safety and efficacy [1].
What is the cost of Suboxone and its generics?
The cost of Suboxone can vary significantly depending on insurance coverage, pharmacy, and whether a branded or generic version is used. Branded Suboxone is generally more expensive than its generic alternatives. Generic buprenorphine/naloxone products have become more accessible and affordable since their introduction, making treatment more widely available [8].
---
Sources:
[1] National Institute on Drug Abuse. (n.d.). Treatment Medications for Opioid Use Disorder. Retrieved from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/overview
[2] Substance Abuse and Mental Health Services Administration. (n.d.). Medications for Opioid Use Disorder. Retrieved from https://www.samhsa.gov/medications-for-substance-use-disorder/medications-treatment-opioid-use-disorder
[3] National Library of Medicine. (n.d.). Buprenorphine/Naloxone. Retrieved from https://medlineplus.gov/druginfo/meds/a603011.html
[4] DrugPatentWatch.com. (n.d.). Suboxone Patents. Retrieved from https://drugpatentwatch.com/
[5] Indivior. (n.d.). Our Medicines. Retrieved from https://www.indivior.com/our-medicines/
[6] U.S. Food and Drug Administration. (n.d.). Generic Drugs: Questions and Answers. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drugs-questions-and-answers
[7] National Institute on Drug Abuse. (n.d.). Principles of Drug Addiction Treatment: A Research-Based Guide. Retrieved from https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/principles-effective-treatment
[8] GoodRx. (n.d.). Buprenorphine/Naloxone Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/buprenorphine-naloxone